Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Carrier-free single-molecule hypoxia-activated nanoprodrug of SN38 with ultrahigh drug loading for pancreatic cancer treatment

Journal of Materials Chemistry B(2025)10.1039/d5tb01434dSource: DataRank Database

Carrier-free single-molecule hypoxia-activated nanoprodrug of SN38 with ultrahigh drug loading for pancreatic cancer treatment is a research paper published in Journal of Materials Chemistry B (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.00)OA: hybridTopics (38)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Mouhmad Elayyan ORCID,Safiya Nisar ORCID,Binglin Sui ORCID,Amrit Regmi ORCID

Live enrichment

PubMed:41091112 OpenAlex:https://openalex.org/W4415011231

National Science Foundation

Grant: CHE-2213445

National Science Foundation

Grant: 2213445

LEAPS-MPS: CAS:Stimuli-Responsive Biodegradable Polymeric Nanomaterials for Biomedical Applications

FWCI

0.00

Citation Percentile

0.2%

hybridLicense: cc-by-nc

journalhttps://pubs.rsc.org/en/content/articlepdf/2025/tb/d5tb01434d

HYBRIDhttps://pubs.rsc.org/en/content/articlepdf/2025/tb/d5tb01434d

publisherhttps://pubs.rsc.org/en/content/articlepdf/2025/tb/d5tb01434d

publisherhttp://pubs.rsc.org/en/content/articlepdf/2025/TB/D5TB01434D

journalhttps://doi.org/10.1039/d5tb01434d

Fields of Study

Nanoplatforms for cancer theranosticsNanoparticle-Based Drug DeliveryGlioma Diagnosis and TreatmentMedicine02 engineering and technology0210 nano-technology

MeSH Terms

IrinotecanAnimalsAntineoplastic AgentsDrug Screening Assays, AntitumorHumansPancreatic NeoplasmsParticle SizeCell Line, TumorCell ProliferationMiceNanoparticlesTumor Microenvironment

Keywords

Pancreatic cancerDrugProdrugSmall moleculeRegimenBioavailabilityNanodeviceToxicityAntineoplastic AgentsIrinotecanPancreatic NeoplasmsMiceCell Line, TumorTumor MicroenvironmentHumansAnimalsNanoparticlesDrug Screening Assays, AntitumorParticle SizeCell Proliferation